Praxis Precision Medicines, Inc. (PRAX) Institutional Ownership & Insider Trading
309 institutions reported holding Praxis Precision Medicines, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 28 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PRAXPraxis Precision Medicines, Inc.Follow PRAX — free
—
Price chart with a free account
- Market cap
- 7.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters309 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +5.5%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 309 | 34 | +5.5% | 118 | 53 | 89 | 30 |
| Mar 26 | 286 | 32 | +6.0% | 116 | 63 | 66 | 30 |
| Dec 25 | 248 | 29 | +19.0% | 86 | 98 | 42 | 15 |
| Sep 25 | 149 | 25 | +1.7% | 55 | 24 | 44 | 16 |
| Jun 25 | 142 | 24 | +3.4% | 63 | 21 | 32 | 29 |
| Mar 25 | 148 | 23 | +9.7% | 46 | 31 | 48 | 44 |
| Dec 24 | 162 | 22 | +15.0% | 51 | 32 | 47 | 9 |
| Sep 24 | 133 | 19 | +1.7% | 42 | 30 | 39 | 11 |
Praxis Precision Medicines, Inc. — questions
- Who owns Praxis Precision Medicines, Inc. stock?
- 309 institutions reported Praxis Precision Medicines, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Jupiter Topco LLC (12.3%), FMR LLC (8.3%), BlackRock, Inc. (8.2%).
- Are Praxis Precision Medicines, Inc. insiders buying or selling?
- 28 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Praxis Precision Medicines, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.